ATR-IN-32
ATR-IN-32 is an orally active ATR inhibitor. ATR-IN-32 potently inhibits the proliferation of MIA PaCa-2 cells. ATR-IN-32 exerts significant tumor growth inhibition in mice bearing LOVO and HT-29 xenografts. ATR-IN-32 can be used for the study of cancers mediated by ATR protein kinase, such as colorectal cancer, pancreatic cancer[1].
Product Specifications
CAS Number
[2902715-97-1]
UNSPSC
12352005
Target
ATM/ATR
Related Pathways
Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Field of Research
Cancer
Purity
96.69
Smiles
N#CC1(CCOCC1)C2=CC(N3[C@@H](COCC3)C)=NC4=C2C=CN=C4C5=NNC=C5
Molecular Formula
C22H24N6O2
Molecular Weight
404.46
References & Citations
[1]XIE, Yuli, et al. NAPHTHYRIDINE DERIVATIVE AS ATR INHIBITOR AND METHOD FOR PREPARING SAME. PCT/CN2022/111893, WO2023/016529 A1. World Intellectual Property Organization (WIPO) International Bureau. 2023-02-16.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
